Modification of extracellular matrix enhances oncolytic adenovirus immunotherapy in glioblastoma. Kiyokawa J, Kawamura Y, Ghouse SM, Acar S, et al. Clin Cancer Res 2020 Nov 30. pii: 1078-0432.CCR-20-2400.

Read + Share

Amedeo Smart

Independent Medical Education

Kiyokawa J, Kawamura Y, Ghouse SM, Acar S, et al. Modification of extracellular matrix enhances oncolytic adenovirus immunotherapy in glioblastoma. Clin Cancer Res 2020 Nov 30. pii: 1078-0432.CCR-20-2400.
PMID: 33257429